OTC Newsline feature advertising reports are intended to be stock ideas, not recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this advertising report was extracted from current documents filed with the SEC, the company website and/or other publicly available sources deemed reliable. The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. For more information see our disclaimer section, a link of which can be found on our website. Actual results may differ materially from the Company's expectations and estimates. The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country.

 All rights reserved. OTCN is not a registered broker/dealer or financial advisor. Before making a purchase or sale of any securities featured on our website, we strongly encourage and recommend consultation with a registered securities representative. This is not to be construed as a solicitation or recommendation to buy or sell securities. OTCN may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. OTCN has been compensated by a third party  for its efforts . As with any stock, companies we select to profile involve a degree of investment risk and volatility. All investors are cautioned that they may lose all or a portion of their investment if they decide to make a purchase in any of our profiled companies.

Disclosure
OTCnewsline.com and/or its affiliates have received 4,166,666 free trading shares from a third party . OTCnewsline.com's affiliates, officers, director, and employees will buy shares in the open market at any time without notice of the company discussed in this profile, and may profit in the event those shares rise in value. OTCnewsline.com will not advise as to when it will decide to sell and does not and will not offer any opinion as to when others should sell; Each reader should make that decision based upon his or her own judgment of the market. However, if an officer, director, employee, entity under any of the latter's control, or an immediate family member is long the stock, that individual or entity may profit when it will decide to sell.